期刊文献+

遗传改造酿酒酵母生产植物萜类药物的策略 被引量:2

The strategy of genetic engineering Saccharomyces cerevisiae to produce the plant-derived terpenoid drugs
原文传递
导出
摘要 植物萜类化合物广泛应用于食品、医药、化妆品、农业等行业,在人们生活中起着越来越重要的作用,但因植物资源有限、生长缓慢、提取工艺复杂、生产成本高等影响,萜类物质在应用上受到很大限制。酵母作为一种简单的真核生物,不但具有遗传背景清晰、生长快、容易操作等优点,而且其本身存在萜类合成途径。因此,酵母常被用作宿主菌,在不影响正常生长的情况下,优化其萜类合成途径,使之适合植物萜类药物的生物合成。本文就萜类的生物合成、近几年改造酵母生产萜类取得的成果和面临的一些问题及建议做一综述。 The plant-derived terpenoids are widely used in the industries of food, medicine, cosmetics as well as agriculture, and it plays an increasingly vital role in the people's life. However, terpenoids of natural sources are unavailable in sufficient amounts to meet the requirement of people's life, because of the slow growth, complexity of extraction techniques and high cost of production, which make its application has been greatly limited. S. cerevisiae, as one kind of simple eukaryotes has the advantages of clear genetic background, fast growth and easy manipulation by genetic engineering. Furthermore, natural biosynthetic pathway of isoprenoids is also found in yeast cells. Therefore, yeast can be take as engineering host to reconstruct the isoprenoid pathway to fit the biosynthesis of plant terpenoids after fermentation. In this article, the biosynthesis process of terpenoids, along with the achievements and problems of engineering yeast to produce terpenoids will be reviewed.
出处 《微生物学通报》 CAS CSCD 北大核心 2015年第10期2019-2025,共7页 Microbiology China
基金 国家自然科学基金青年基金项目(No.31100029) 中央高校基本科研业务费(No.CQDXWL)
关键词 遗传改造 酿酒酵母 萜类物质 Genetic reconstruct, Saccharomyces cerevisiae, Terpenoids
  • 相关文献

参考文献52

  • 1Baunach M, Franke J, Hertweck C. Terpenoid biosynthesis off the beaten track: unconventional cyclases and their impact on biomimetic synthesis[J]. Angewandte Chemic, 2015, 54(9): 2604-2626. 被引量:1
  • 2Visser B J, Wieten RW, Kroon D, et al. Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review[J]. Malaria Journal, 2014, 13(1): 463. 被引量:1
  • 3Auparakkitanon, S. Discovery and development of antiplasmodial compounds in Thailand during the 21st century[J]. The Southeast Asian Journal of Tropical Medicine Public Health, 2014, 45(4): 761-782. 被引量:1
  • 4Tran TA, Gillet L, Roger S, et al. Non-anti-mitotic concentrations of taxol reduce breast cancer cell invasiveness[J]. Biochemical and Biophysical Research Communications, 2009, 379(2): 304-308. 被引量:1
  • 5Miller K, Neilan B, Sze DM. Development of Taxol and other endophyte produced anti-cancer agents[J]. Recent Patents on Anticancer Drug Discovery, 2008, 3(1): 14-19. 被引量:1
  • 6Walsh V, Goodman J. From taxol to Taxol: the changing identities and ownership of an anti-cancer drug[J]. Medical Anthropology, 2002, 21(3/4): 307-336. 被引量:1
  • 7Wang XY, Wang YG, Wang YF. Ginsenoside Rbl, Rgl and three extracts of traditional Chinese medicine attenuate ultraviolet B-induced G1 growth arrest in HaCaT cells and dermal fibroblasts involve down-regulating the expression of p16, p21 and p53[J]. Photodermatology Photoimmunology and Photomedicine, 2011, 27(4): 203-212. 被引量:1
  • 8Lee CH, Kim JH. A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases[J]. Journal of Ginseng Research, 2014, 38(3): 161-166. 被引量:1
  • 9Feofilova EP, Tereshina VM, Memorskaia AS, et al. Fungal lycopene: the biotechnology of its production and prospects for its application in medicine[J]. Mikrobiologiia, 2006, 75(6): 725-730. 被引量:1
  • 10Lee CO. Complementary and alternative medicine patients are talking about: lyeopene[J]. Clinical Journal of Ontology Nursing, 2005, 9(2): 245-246. 被引量:1

二级参考文献4

共引文献17

同被引文献26

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部